Cargando…
Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions
BACKGROUND: Estimating the optimal threshold (and especially the confidence interval) of a quantitative biomarker to be used as a diagnostic test is essential for medical decision-making. This is often done with simple methods that are not always reliable. More advanced methods work well but only fo...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062774/ https://www.ncbi.nlm.nih.gov/pubmed/24927622 http://dx.doi.org/10.1186/1472-6947-14-53 |
_version_ | 1782321687751032832 |
---|---|
author | Subtil, Fabien Rabilloud, Muriel |
author_facet | Subtil, Fabien Rabilloud, Muriel |
author_sort | Subtil, Fabien |
collection | PubMed |
description | BACKGROUND: Estimating the optimal threshold (and especially the confidence interval) of a quantitative biomarker to be used as a diagnostic test is essential for medical decision-making. This is often done with simple methods that are not always reliable. More advanced methods work well but only for biomarkers with very simple distributions. In fact, biomarker distributions are often complex because of a natural heterogeneity in marker expression and other heterogeneities due to various disease stages, laboratory equipments, etc. Methods are required to estimate a biomarker optimal threshold in case of heterogeneity and complex distributions. METHODS: A previously described Bayesian method developed for normally distributed biomarkers is applied to two flexible distributions; namely, a Student-t and a mixture of Dirichlet processes. Here, numerical studies assess the adequacy of the previous method with both distributions. Two applications are presented: the diagnosis of treatment failure after prostate cancer treated by ultrasound and the early diagnosis of cancers of the upper aerodigestive tract. RESULTS: Bayesian inference provided reliable credible intervals in terms of bias and coverage probability. The two distributions analysed gave meaningful clinical interpretations in both applications. CONCLUSIONS: Reliable methods can be used to estimate a biomarker optimal threshold, even in case of complex distributions. |
format | Online Article Text |
id | pubmed-4062774 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2014 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-40627742014-06-27 Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions Subtil, Fabien Rabilloud, Muriel BMC Med Inform Decis Mak Research Article BACKGROUND: Estimating the optimal threshold (and especially the confidence interval) of a quantitative biomarker to be used as a diagnostic test is essential for medical decision-making. This is often done with simple methods that are not always reliable. More advanced methods work well but only for biomarkers with very simple distributions. In fact, biomarker distributions are often complex because of a natural heterogeneity in marker expression and other heterogeneities due to various disease stages, laboratory equipments, etc. Methods are required to estimate a biomarker optimal threshold in case of heterogeneity and complex distributions. METHODS: A previously described Bayesian method developed for normally distributed biomarkers is applied to two flexible distributions; namely, a Student-t and a mixture of Dirichlet processes. Here, numerical studies assess the adequacy of the previous method with both distributions. Two applications are presented: the diagnosis of treatment failure after prostate cancer treated by ultrasound and the early diagnosis of cancers of the upper aerodigestive tract. RESULTS: Bayesian inference provided reliable credible intervals in terms of bias and coverage probability. The two distributions analysed gave meaningful clinical interpretations in both applications. CONCLUSIONS: Reliable methods can be used to estimate a biomarker optimal threshold, even in case of complex distributions. BioMed Central 2014-06-14 /pmc/articles/PMC4062774/ /pubmed/24927622 http://dx.doi.org/10.1186/1472-6947-14-53 Text en Copyright © 2014 Subtil and Rabilloud; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. |
spellingShingle | Research Article Subtil, Fabien Rabilloud, Muriel Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions |
title | Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions |
title_full | Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions |
title_fullStr | Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions |
title_full_unstemmed | Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions |
title_short | Estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions |
title_sort | estimating the optimal threshold for a diagnostic biomarker in case of complex biomarker distributions |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4062774/ https://www.ncbi.nlm.nih.gov/pubmed/24927622 http://dx.doi.org/10.1186/1472-6947-14-53 |
work_keys_str_mv | AT subtilfabien estimatingtheoptimalthresholdforadiagnosticbiomarkerincaseofcomplexbiomarkerdistributions AT rabilloudmuriel estimatingtheoptimalthresholdforadiagnosticbiomarkerincaseofcomplexbiomarkerdistributions |